These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16953631)

  • 1. Synthetic studies of complex immunostimulants from Quillaja saponaria: synthesis of the potent clinical immunoadjuvant QS-21Aapi.
    Kim YJ; Wang P; Navarro-Villalobos M; Rohde BD; Derryberry J; Gin DY
    J Am Chem Soc; 2006 Sep; 128(36):11906-15. PubMed ID: 16953631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of the potent immunostimulatory adjuvant QS-21A.
    Wang P; Kim YJ; Navarro-Villalobos M; Rohde BD; Gin DY
    J Am Chem Soc; 2005 Mar; 127(10):3256-7. PubMed ID: 15755124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and structure verification of the vaccine adjuvant QS-7-Api. Synthetic access to homogeneous Quillaja saponaria immunostimulants.
    Deng K; Adams MM; Gin DY
    J Am Chem Soc; 2008 May; 130(18):5860-1. PubMed ID: 18410100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semisynthesis of Analogues of the Saponin Immunoadjuvant QS-21.
    Fernández-Tejada A; Walkowicz WE; Tan DS; Gin DY
    Methods Mol Biol; 2017; 1494():45-71. PubMed ID: 27718185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of Improved Vaccine Adjuvants Based on the Saponin Natural Product QS-21 through Chemical Synthesis.
    Fernández-Tejada A; Tan DS; Gin DY
    Acc Chem Res; 2016 Sep; 49(9):1741-56. PubMed ID: 27568877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of potent Quillaja saponin vaccine adjuvants.
    Adams MM; Damani P; Perl NR; Won A; Hong F; Livingston PO; Ragupathi G; Gin DY
    J Am Chem Soc; 2010 Feb; 132(6):1939-45. PubMed ID: 20088518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural and synthetic saponin adjuvant QS-21 for vaccines against cancer.
    Ragupathi G; Gardner JR; Livingston PO; Gin DY
    Expert Rev Vaccines; 2011 Apr; 10(4):463-70. PubMed ID: 21506644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
    Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
    Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QS-21 Adjuvant: Laboratory-Scale Purification Method and Formulation Into Liposomes.
    Brunner L; Barnier-Quer C; Collin N
    Methods Mol Biol; 2017; 1494():73-86. PubMed ID: 27718186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foamy matters: an update on
    Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
    Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QS-21 and QS-7: purified saponin adjuvants.
    Kensil CR; Wu JY; Anderson CA; Wheeler DA; Amsden J
    Dev Biol Stand; 1998; 92():41-7. PubMed ID: 9554258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Versatile strategy for the divergent synthesis of linear oligosaccharide domain variants of Quillaja saponin vaccine adjuvants.
    Fernández-Tejada A; Tan DS; Gin DY
    Chem Commun (Camb); 2015 Sep; 51(73):13949-52. PubMed ID: 26243268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in saponin-based adjuvants.
    Sun HX; Xie Y; Ye YP
    Vaccine; 2009 Mar; 27(12):1787-96. PubMed ID: 19208455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of the saponin adjuvant QS-21 and its base-catalyzed isomerization product by 1H and natural abundance 13C NMR spectroscopy.
    Jacobsen NE; Fairbrother WJ; Kensil CR; Lim A; Wheeler DA; Powell MF
    Carbohydr Res; 1996 Jan; 280(1):1-14. PubMed ID: 8581890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review.
    Lacaille-Dubois MA
    Phytomedicine; 2019 Jul; 60():152905. PubMed ID: 31182297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predominant Quillaja Saponaria fraction, QS-18, is safe and effective when formulated in a liposomal murine cancer peptide vaccine.
    Zhou S; Song Y; Nilam A; Luo Y; Huang WC; Long MD; Lovell JF
    J Control Release; 2024 May; 369():687-695. PubMed ID: 38575073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure Elucidation of Triterpenoid Saponins Found in an Immunoadjuvant Preparation of
    Wallace F; Fontana C; Ferreira F; Olivaro C
    Molecules; 2022 Apr; 27(8):. PubMed ID: 35458600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of the trisaccharide portion of the immunologic adjuvant QS-21A via sulfonium-mediated oxidative and dehydrative glycosylation.
    Kim YJ; Gin DY
    Org Lett; 2001 Jun; 3(12):1801-4. PubMed ID: 11405715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.